Lipid Forum-6
|
08:00-10:00 103C |
|---|
| 主持 Moderators | 邱原刚 Yuangang QIU, 周鹏 Peng ZHOU, 陈晓曙 Xiaoshu CHEN, 李国栋 Guodong LI, 钟海江 Haijiang ZHONG, 章瑾瑜 Jinyu ZHANG | ||
|
08:00-08:20 |
Pcsk9i降脂治疗低反应与LDL-R受体变异 Low Response to PCSK9i Lipid-Lowering Therapy and LDL-R Receptor Variation |
张钲 Zheng ZHANG | |
|
08:20-08:40 |
高甘油三酯血症的现状与管理新策略 Current Status and New Management Strategies of Hypertriglyceridemia |
傅国胜 Guosheng FU | |
|
08:40-09:00 |
心血管风险极高危患者联合降脂治疗策略 Combined Lipid-Lowering Therapy Strategy for Patients at Extremely High Cardiovascular Risk |
白锋 Feng BAI | |
|
09:00-09:20 |
“他汀不耐受的临床诊断与处理中国专家共识”解读 Interpretation of the “Chinese Expert Consensus on Clinical Diagnosis and Management of Statin Intolerance” |
赵兴胜 Xingsheng ZHAO | |
|
09:20-09:40 |
高血压患者的血脂管理策略 Lipid Management Strategy for Hypertensive Patients |
张新军 Xinjun ZHANG | |
|
09:40-10:00 |
2025 ESC/EAS血脂管理指南 重点更新 Key Updates of the 2025 ESC/EAS Guidelines for Lipid Management |
于汇民 Huimin YU | |
Lipid Forum-7
|
10:00-12:00 103C |
|---|
| 主持 Moderators | 谢峻 Jun XIE, 陈国雄 Guoxiong CHEN, 陈铁龙 Tielong CHEN, 沈剑耀 Jianyao SHEN, 季晓君 Xiaojun JI | ||
|
10:00-10:20 |
诊室外血压测量进展 Progress in Out-of-Clinic Blood Pressure Measurement |
陈晓平 Xiaoping CHEN | |
|
10:20-10:40 |
后他汀时代的血脂管理新策略：从残余风险控制到精准治疗 New Lipid Management Strategies in the Post-Statin Era: From Residual Risk Control to Precision Treatment |
柴大军 Dajun CHAI | |
|
10:40-11:00 |
鱼油的多靶点效应与糖尿病人群心血管获益的相关性再探讨 Re-exploration of the Correlation Between the Multi-Target Effect of Fish Oil and Cardiovascular Benefits in Diabetic Population |
王长谦 Changqian WANG | |
|
11:00-11:20 |
应激损伤与心血管风险认识与策略 Understanding and Strategy of Stress Injury and Cardiovascular Risk |
刘梅颜 Meiyan LIU | |
|
11:20-11:40 |
APOC3靶向降脂药物新突破 Emerging Frontiers in APOC3-Targeted Lipid-Lowering Therapy |
高秀芳 Xiufang GAO | |
|
11:40-12:00 |
血脂药物最新研究进展解读 Interpretation of the Latest Research Progress of Lipid-Lowering Drugs |
常静 Jing CHANG | |